Universal Cancer Peptide-based Vaccination in Metastatic NSCLC

Clinical trial NCT02818426 · COMPLETED

Trial details

NCT number: NCT02818426
Sponsor: Centre Hospitalier Universitaire de Besancon
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Metastatic Non-small Cell Lung Cancer

Start date: 2016-04-20
Primary completion: 2022-08-30
Enrollment: 82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.